Can Renal Denervation Reduce Heart Attack, Stroke and Death?

Renal denervation, a catheter-based procedure designed to lower blood pressure, has been the subject of much interest to the interventional community over the past couple of years. Although high blood pressure puts one in three adults worldwide at risk of heart attack, stroke and kidney failure, the renal denervation studies that have been conducted to date have looked only at reducing blood pressure rather than the overall impact on major cardiac events. St. Jude's (NYSE:STJ) announcement today of the EnligHTNment trial is the first that will look at "hard end points" such as heart attack, stroke and mortality.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news